No paralogue variants have been mapped to residue 13 for RYR1.
RYR1 | MGD-AE-GEDEVQF>L<RTDDEVVLQCSATVLKEQLKLCLAAEGFGN | 43 |
RYR2 | MADGGE-GEDEIQF>L<RTDDEVVLQCTATIHKEQQKLCLAAEGFGN | 44 |
RYR3 | MAEGGEGGEDEIQF>L<RTEDEVVLQCIATIHKEQRKFCLAAEGLGN | 45 |
cons | > < |
Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
---|---|---|---|---|---|
p.L13V | c.37C>G | Other Myopathy | SIFT: Polyphen: | ||
Reports | Other Myopathy | Null mutations causing depletion of the type 1 ryanodine receptor (RYR1) are commonly associated with recessive structural congenital myopathies with cores. Hum Mutat. 2008 29(5):670-8. 18253926 | |||
p.L13R | c.38T>G | Other Myopathy | rs193922744 | SIFT: Polyphen: | |
Reports | Other Myopathy | Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat. 2006 27(10):977-89. 16917943 | |||
Other Myopathy | Disease mutations in the ryanodine receptor N-terminal region couple to a mobile intersubunit interface. Nat Commun. 2013 4:1506. doi: 10.1038/ncomms2501. 23422674 | ||||
Other Myopathy | Ryanodine receptor type 1 gene variants in the malignant hyperthermia-susceptible population of the United States. Anesth Analg. 2013 116(5):1078-86. doi: 10.1213/ANE.0b013e31828a71ff. 23558838 |